1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow YJ001 for Spray Use: new trials by email Literature Review of YJ001 for Spray Use trials Research Report on YJ001 for Spray Use
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP YJ001 for Spray Use, Placebo of YJ001 for Spray Use - Diabetic Peripheral Neuropathic Pain | Phase 1 | Recruiting | Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | 24 | 2024-05-16 | 2025-08-13 |
| Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers YJ001 for Spray Use, Placebo of YJ001 for Spray Use - Safety and Tolerability | Phase 1 | Completed | Yuejia Pharmaceuticals (USA), Inc. | 32 | 2022-08-15 | 2023-01-04 |
Yuejia Pharmaceuticals (USA), Inc. (1) · Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. (1)
United States (2)